194044-54-7 ((4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonami de)

4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonami de;Hsdb 7038;Ccris 9330;p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide;4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide;Celecoxib [USAN];CELECOXIB [INN];184007-95-2;Xilebao;SPBio_001512;ELYXYB;DFN15;CELECOXIB [VANDF];Celebrex;HMS3867I03;BC164295;KBioSS_002354;cMAP_000027;Onsenal (TN);A25046;Celecoxib 200 mg;4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide;KBio3_003037;HMS502M15;TPI-336;AB00052396-08;Celecoxib 400 mg;DTXSID0022777;BDBM11639;HY-14398;GTPL2892;194044-54-7;CELECOXIB [EMA EPAR];BCP02156;KBio2_000912;Q-200816;MLS006011862;CELECOXIB (USP-RS);KS-1041;4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE;CELECOXIB [JAN];KBio3_002830;AM84588;EN300-119504;D00567;KBio2_007487;Tox21_111135_1;Celecoxibum;benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-;J-010566;Celecixib;Celecoxib [USAN:INN:BAN];HMS3654H09;HMS2093I07;NCGC00091455-05;KBioGR_002351;BP-30217;AB00052396-07;J-520011;169590-42-5;NC00708;NCGC00091455-06;BCPP000290;SC 58635;Solexa;NCGC00259513-01;NCI60_041049;YM 177;CELECOXIB COMPONENT OF CONSENSI;NSC-719627;SB19318;Celebrex (TN);CELECOXIB (USP MONOGRAPH);CJ-016377;SR-01000837528-2;CS-0570;Celecoxib, European Pharmacopoeia (EP) Reference Standard;DFN-15;NSC719627;KBioSS_000912;cid_2662;Tox21_300599;BCP9000507;4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-pyrazol-1-yl]benzenesulfonamide;4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide;s1261;KBio1_000893;CP-598107;4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide;DB00482;HMS3373A09;Celecoxib 1.0 mg/ml in Acetonitrile;4-[5-(p-Tolyl)-3-(trifluoromethyl)-1-pyrazolyl]benzenesulfonamide;Onsenal;SCHEMBL3708;AKOS015842517;AB00052396-09;Celebra;STL373576;SR-01000837528;NCGC00091455-02;Spectrum5_001324;MLS001195656;HMS1922G14;NCGC00091455-04;MFCD00941298;NINDS_000893;4-[5-(p-tolyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide;KBio2_004919;SW199611-3;Celecoxib (JAN/USP/INN);BRD-K02637541-001-06-5;HMS3884M07;5-(4-Methylphenyl)-1-(4-sulfamoylphenyl)-3-(trifluoromethyl)pyrazole;HY-14398GL;Generic Drug;PF-00345549;Celecoxib 50 mg;AC-4228;CELECOXIB [HSDB];Tox21_201964;NCGC00091455-13;HMS2234N18;Tox21_111135;NCGC00261091-01;UNII-JCX84Q7J1L;SY064976;CS-0901612;CELECOXIB [MART.];L01XX33;NCGC00091455-03;1oq5;NSC 719627;SR-01000837528-3;SC58635;CELECOXIB (EP MONOGRAPH);Pharmakon1600-01503678;Celecoxib- Bio-X;US8741944, Comparative Compound;Q408801;CAS-169590-42-5;Celecoxib, >=98% (HPLC);CELECOXIB [WHO-DD];IDI1_000893;4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide;CELECOXIB [MI];SBI-0051875.P002;Spectrum_000432;HMS3715F11;Z1258938406;CELECOXIB [USP MONOGRAPH];NSC-758624;CELECOXIB [USP-RS];HMS3259L08;NCGC00254540-01;C07589;CCG-39354;BRD-K02637541-001-02-4;4-(5-p-tolyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide;KBio2_002351;HMS3261A14;KBioGR_000723;PHA-00846533;Celecoxib (GMP Like);ELYXYB-celecoxib;NS00002556;Celecoxib, United States Pharmacopeia (USP) Reference Standard;Celecoxib, Pharmaceutical Secondary Standard; Certified Reference Material;Celecox;JCX84Q7J1L;NCGC00091455-09;CEP-33222;AI-525;CELECOXIB [ORANGE BOOK];MLS001165684;Tox21_500406;Benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-;Spectrum2_001576;CHEMBL118;4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyazol-1-yl]benezenesulfonamide;C2816;AB00052396_11;KBio2_006048;BSPBio_003596;SMR000550473;CELECOXIB [EP MONOGRAPH];NSC 758624;CONSENSI COMPONENT CELECOXIB;CELECOXIB (MART.);Spectrum4_000182;NCGC00091455-07;M01AH01;EX-A175;CHEBI:41423;MLS001304708;celecoxib;KBio2_003480;Spectrum3_001996;HMS2089L18;NCGC00091455-08;Celocoxib;SPECTRUM1503678;NSC758624;4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-pyrazol-1-yl]benzenesulfonamide;Celecoxib 100 mg;DTXCID502777;DivK1c_000893;CELEBCOXIB;UNM-0000305813;4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide;Benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-;AB00052396_10;BBL029086;NCGC00091455-01;YM-177;BIDD:GT0408;SC-58635;YM177;

RZEKVGVHFLEQIL-UHFFFAOYSA-N

1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)

S(C1C=CC(=CC=1)N1C(=CC(C(F)(F)F)=N1)C1C=CC(C)=CC=1)(N)(=O)=O